Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0551 USD | 0.00% | -5.97% | +48.92% |
04-25 | North American Morning Briefing : More Tech -2- | DJ |
04-11 | North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge | DJ |
Business Summary
Number of employees: 18
Managers
Managers | Title | Age | Since |
---|---|---|---|
Craig Jalbert
CEO | Chief Executive Officer | 63 | - |
Martin Dekker
CTO | Chief Tech/Sci/R&D Officer | 51 | 28/01/15 |
Edwin L. Parsley
CTO | Chief Tech/Sci/R&D Officer | 63 | - |
Bobae Kim
LAW | General Counsel | 42 | 31/08/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Naseem Amin
CHM | Chairman | 62 | 28/06/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 12,232,648 | 10,394,477 ( 84.97 %) | 0 | 84.97 % |
Company contact information
Bellerophon Therapeutics, Inc.
184 Liberty Corner Road Suite 302
07059, Warren
+908 574 4770
http://www.bellerophon.comSector
1st Jan change | Capi. | |
---|---|---|
+48.92% | 674K | |
-3.16% | 102B | |
+1.66% | 96.29B | |
+2.13% | 22.18B | |
-15.86% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.71% | 16.36B | |
+5.99% | 13.97B | |
+33.97% | 12.17B |
- Stock Market
- Equities
- BLPH Stock
- Company Bellerophon Therapeutics, Inc.